Form 4: Martha Shadan, Director at LeMaitre Vascular, Reports Acquisition of Dividend Equivalent Rights

Director Martha Shadan reports acquiring dividend equivalent rights related to restricted stock units and performance share units.

Summary

• On March 27, 2025, Martha Shadan, a director at LeMaitre Vascular, reported the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted.
• The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
• The acquired rights are the economic equivalent of shares of LeMaitre Vascular's common stock.
• The transactions did not involve any monetary exchange, with the price reported as $0.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.
• The vesting schedule tied to the RSUs and PSUs may incentivize long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the acquisition of dividend equivalent rights, which are common in equity compensation plans.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders.
• It reflects ongoing compensation practices for company directors.

Key Dates

Keywords

dividend equivalent rights, Form 4, LMAT, LeMaitre Vascular, Martha Shadan, Director, RSU, PSU, Beneficial Ownership